Format

Send to

Choose Destination
Antiviral Res. 2011 Apr;90(1):98-101. doi: 10.1016/j.antiviral.2011.02.007. Epub 2011 Feb 26.

Potential of adenovirus and baculovirus vectors for the delivery of shRNA against morbilliviruses.

Author information

1
CIRAD, UMR ContrĂ´le des Maladies, Montpellier F-34398, France.

Abstract

Morbilliviruses are important pathogens of humans, ruminants, carnivores and marine mammals. Although good vaccines inducing long-term immunity are available, recurrent outbreaks of measles, canine distemper and peste des petits ruminants (PPR) are observed. In control strategies, antivirals thus could be useful to confine virus spread and application of interfering RNAs is a promising approach, provided they can be delivered efficiently into the host cells. We have constructed recombinant adenovirus and baculovirus vectors expressing short hairpin RNAs (shRNAs) against the PPR virus (PPRV) and compared them in vitro. It was found that both recombinant viruses inhibited PPRV replication with the baculovirus vector, which inhibited generation of infectious progeny by more than 2 log10 and the nucleoprotein expression of PPRV by 73%, being the more efficient. The results show that baculoviral shRNA-expressing vectors have the potential for therapeutic use against morbillivirus infections.

PMID:
21356246
DOI:
10.1016/j.antiviral.2011.02.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center